Literature DB >> 14616225

Clinical correlates of early medication adherence: West London first episode schizophrenia study.

S H Mutsatsa1, E M Joyce, S B Hutton, E Webb, H Gibbins, S Paul, T R E Barnes.   

Abstract

OBJECTIVE: Little is known about factors that mediate adherence with medication during the early stages of antipsychotic treatment in schizophrenia. This study sought to identify factors that may be associated with medication adherence in first-episode schizophrenia.
METHOD: In 101 patients, adherence was assessed along with potentially relevant variables, including attitudes toward medication, insight, substance misuse, side effects and psychopathology.
RESULTS: In a linear regression analysis, negative attitudes toward medication and a relative lack of insight contributed significantly towards poor adherence. Although poorly adherent patients had significantly higher scores on negative and disorganization syndromes, these did not contribute significantly towards adherence. Adverse medication side effects, subjective well-being and substance misuse showed no significant association with adherence.
CONCLUSION: At the initiation of drug treatment, attitudes toward medication and insight appear more relevant to medication adherence than side effects. Adherence appears to reflect a complex interaction of influences, which may change over time.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14616225     DOI: 10.1046/j.0001-690x.2003.00193.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  23 in total

Review 1.  Lack of insight in schizophrenia: impact on treatment adherence.

Authors:  Peter F Buckley; Donna A Wirshing; Prameet Bhushan; Joseph M Pierre; Seth A Resnick; William C Wirshing
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 2.  Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review.

Authors:  Tania M Lincoln; Eva Lüllmann; Winfried Rief
Journal:  Schizophr Bull       Date:  2007-02-08       Impact factor: 9.306

3.  Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review.

Authors:  Prakash S Masand; Miquel Roca; Martin S Turner; John M Kane
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

4.  Predictors of medication non-adherence in Bulgarian outpatients with schizophrenia.

Authors:  Iglika Vassileva; Vihra Milanova; Turan Asan
Journal:  Community Ment Health J       Date:  2014-01-23

5.  Medication adherence in first episode psychosis: the role of pre-onset subthreshold symptoms.

Authors:  J-G Daneault; A Maraj; M Lepage; A Malla; N Schmitz; S N Iyer; R Joober; J L Shah
Journal:  Acta Psychiatr Scand       Date:  2019-04       Impact factor: 6.392

6.  Medication adherence in schizophrenia: exploring patients', carers' and professionals' views.

Authors:  Martijn J Kikkert; Aart H Schene; Maarten W J Koeter; Debbie Robson; Anja Born; Hedda Helm; Michela Nose; Claudia Goss; Graham Thornicroft; Richard J Gray
Journal:  Schizophr Bull       Date:  2006-08-03       Impact factor: 9.306

7.  Description of study population and analysis of factors influencing adherence in the observational Italian study "Evaluation of Pharmacotherapy Adherence in Bipolar Disorder" (EPHAR).

Authors:  Alessandra Barraco; Andrea Rossi; Giuseppe Nicolò
Journal:  CNS Neurosci Ther       Date:  2010-12-28       Impact factor: 5.243

8.  The predictive validity of subjective adherence measures in patients with schizophrenia.

Authors:  Martijn J Kikkert; Maarten W J Koeter; Jack J M Dekker; Lorenzo Burti; Debbie Robson; Bernd Puschner; Aart H Schene
Journal:  Int J Methods Psychiatr Res       Date:  2011-06       Impact factor: 4.035

9.  Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia.

Authors:  Somaia Mohamed; Robert Rosenheck; Joseph McEvoy; Marvin Swartz; Scott Stroup; Jeffrey A Lieberman
Journal:  Schizophr Bull       Date:  2008-06-26       Impact factor: 9.306

10.  The RAISE Connection Program: Psychopharmacological Treatment of People With a First Episode of Schizophrenia.

Authors:  Julie A Kreyenbuhl; Deborah R Medoff; Joseph P McEvoy; Thomas E Smith; Ann L Hackman; Ilana R Nossel; Lisa B Dixon; Susan M Essock; Robert W Buchanan
Journal:  Psychiatr Serv       Date:  2016-07-01       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.